Home / Inspections / 1022686

1022686

AstraZeneca Pharmaceuticals, LP — FEI 2517100

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newark, DE (United States)

Facility

Other inspections at this facility

  • 1211584 (NAI Wed Jul 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895233 (VAI Wed Aug 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 788561 (NAI Mon Nov 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 737328 (VAI Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 611523 (NAI Thu Sep 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
241921 CFR 211.198(a)Complaint Handling Procedure